Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a null hypothesis study. The investigators hypothesize that there will be no
difference in changes in dynamic compliance when measured at 15, 30, 45 and 60 minute
intervals after administration of either surfactant and there will be no differences in the
number of doses needed between the two surfactants in premature infants admitted to our NICU.
Phase:
N/A
Details
Lead Sponsor:
University of Michigan
Collaborators:
Cornerstone Pharmaceuticals, Inc. Rafael Pharmaceuticals Inc.